1,2-dipalmitoyl-3-phosphatidylethanolamine has been researched along with technetium in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahkong, QF; Tilcock, C | 1 |
| Szucs, M; Tilcock, C | 1 |
| Cossu, F; Melis, G; Rombi, G | 1 |
| Ahkong, QF; Fisher, D; Tilcock, C | 1 |
4 other study(ies) available for 1,2-dipalmitoyl-3-phosphatidylethanolamine and technetium
| Article | Year |
|---|---|
Attachment of 99mTc to lipid vesicles containing the lipophilic chelate dipalmitoylphosphatidylethanolamine-DTTA.
Topics: Animals; Female; Liposomes; Pentetic Acid; Phosphatidylethanolamines; Rats; Rats, Sprague-Dawley; Technetium; Tissue Distribution | 1992 |
Lyophilization and rehydration of polymer-coated lipid vesicles containing a lipophilic chelator in the presence of sucrose: labeling with 99mTc and biodistribution studies.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Chelating Agents; Drug Carriers; Freeze Drying; Humans; Liposomes; Metabolic Clearance Rate; Pentetic Acid; Phosphatidylethanolamines; Polyethylene Glycols; Rabbits; Sucrose; Technetium; Time Factors; Tissue Distribution; Water | 1995 |
mAb-labeled liposomes in breast cancer cell targeting. Therapeutics and diagnostic use of polyspecific artificial carriers.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antibodies, Monoclonal; Brain Neoplasms; Breast Neoplasms; Drug Carriers; Female; Humans; Iodine Radioisotopes; Liposomes; Liver Neoplasms; Neoplasm Metastasis; Phosphatidylethanolamines; Radioimmunodetection; Technetium | 1993 |
Polymer-derivatized technetium 99mTc-labeled liposomal blood pool agents for nuclear medicine applications.
Topics: Animals; Drug Design; G(M1) Ganglioside; Half-Life; Indium Radioisotopes; Liposomes; Pentetic Acid; Phosphatidylethanolamines; Polyethylene Glycols; Rabbits; Technetium | 1993 |